Back | Next |
home / stock / abt / abt message board
Subject | By | Source | When |
---|---|---|---|
$ABT 2Q22 CC transcript: | DewDiligence | investorshub | 07/20/2022 4:54:05 PM |
$ABT 2Q22 Results by Business Segment | DewDiligence | investorshub | 07/20/2022 4:49:57 PM |
$ABT reports 2Q22 resultsraises 2022 EPS guidance: | DewDiligence | investorshub | 07/20/2022 11:58:11 AM |
Should be $150+ | wiwineguy | investorshub | 07/16/2022 12:41:51 AM |
FDA approves $ABTs Freestyle Libre 3the most advanced | DewDiligence | investorshub | 05/31/2022 4:09:16 PM |
$ABT is developing a monkeypox diagnostic: | DewDiligence | investorshub | 05/26/2022 10:47:38 PM |
should be $140 | NOLA1961 | investorshub | 05/18/2022 1:11:10 PM |
$ABT $120 TARGET PRICE TODAY | weedtrader420 | investorshub | 05/17/2022 11:23:34 AM |
It was hit pretty hard in February, when | DewDiligence | investorshub | 05/13/2022 3:09:53 PM |
Surprised the stock wasn't hit massively......... | Termite7 | investorshub | 05/13/2022 1:50:21 PM |
$ABT infant-formula plant expected back online soon: | DewDiligence | investorshub | 05/11/2022 9:37:24 PM |
Thanks. Was looking for a non Seeking alpha source | Hunting_for_multiples | investorshub | 04/22/2022 1:32:06 AM |
1Q22 FreeStyle Libre sales were $1.0B (yes, a | DewDiligence | investorshub | 04/20/2022 10:00:32 PM |
$ABT 1Q22 CC transcript: | DewDiligence | investorshub | 04/20/2022 9:28:12 PM |
$ABT 1Q22 Results by Business Segment | DewDiligence | investorshub | 04/20/2022 4:57:11 PM |
$ABT sold $3.3B of COVID diagnostics in 1Q22: | DewDiligence | investorshub | 04/20/2022 2:49:15 PM |
CDC unable to link infant-formula contamination to $ABTs manufacturing plant: | DewDiligence | investorshub | 04/18/2022 3:08:21 PM |
$ABT fell 6% cumulatively on Thu/Fri due to infant-formula recall: | DewDiligence | investorshub | 02/21/2022 5:47:18 PM |
$ABT 4Q21 CC transcript: | DewDiligence | investorshub | 01/27/2022 12:48:13 AM |
$ABT 4Q21 Results by Business Segment | DewDiligence | investorshub | 01/26/2022 5:18:35 PM |
News, Short Squeeze, Breakout and More Instantly...
2024-07-02 09:15:03 ET Evercore ISI analyst issues OUTPERFORM recommendation for ABT on July 2, 2024 07:59AM ET. The previous analyst recommendation was Outperform. ABT was trading at $103.2 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
2024-06-28 12:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Abbott's Global Sustainability Report shares how we're focused on helping more people, now and in the years ahead. NORTHAMPTON, MA / ACCESSWIRE / June 25, 2024 / At Abbott, we've embedded sustainability across our business - which is helping us to deliver solid progress toward the goals we ...